Recombinant Human Granulocyte Colony-Stimulating Market Report

Global and China Recombinant Human Granulocyte Colony-Stimulating Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 03, 2022
  • PAGES：190
  • REPORT CODE：GMM1431747
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Recombinant Human Granulocyte Colony-Stimulating industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Triprime

    • Sinovac

    • Kyowa Hakko Kirin

    • Zhaoke

    • Hangzhou Jiuyuan

    • Kawin

    • Amoytop Biotech

    • Shijiazhuang Pharmaceutical

    • Amgen

    • Gensci

    • Qilu Pharmaceutical

    • Huaxin

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Lenograstim (Granocyte)

    • Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)

    • Others

    Application:

    • Chemotherapy Induced Neutropenia

    • Before Blood Donation

    • Stem Cell Transplants

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Recombinant Human Granulocyte Colony-Stimulating Industry Overview

      • 1.1.1 Recombinant Human Granulocyte Colony-Stimulating Market Scope and Market Segments

      • 1.1.2 Recombinant Human Granulocyte Colony-Stimulating Industry Characteristics

      • 1.1.3 Global and China Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Recombinant Human Granulocyte Colony-Stimulating Production Value and Growth Rate (2017-2028)

    • 1.2 Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Lenograstim (Granocyte)

      • 1.2.2 Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)

      • 1.2.3 Others

    • 1.3 Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Chemotherapy Induced Neutropenia

      • 1.3.2 Before Blood Donation

      • 1.3.3 Stem Cell Transplants

      • 1.3.4 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Recombinant Human Granulocyte Colony-Stimulating Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Recombinant Human Granulocyte Colony-Stimulating Industry Porter's Five Forces Model Analysis

      • 2.2.3 Recombinant Human Granulocyte Colony-Stimulating Industry PEST Analysis

    • 2.3 Recombinant Human Granulocyte Colony-Stimulating Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Recombinant Human Granulocyte Colony-Stimulating Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Recombinant Human Granulocyte Colony-Stimulating Industry

    Chapter 3 Global and China Recombinant Human Granulocyte Colony-Stimulating Market, by Manufacturer

    • 3.1 Global and China Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Recombinant Human Granulocyte Colony-Stimulating Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Recombinant Human Granulocyte Colony-Stimulating Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Recombinant Human Granulocyte Colony-Stimulating Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Recombinant Human Granulocyte Colony-Stimulating Market Top 3 Players

    Chapter 4 Global and China Recombinant Human Granulocyte Colony-Stimulating Market, by Type (2017-2028)

    • 4.1 Recombinant Human Granulocyte Colony-Stimulating Market Trend, by Type

    • 4.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Recombinant Human Granulocyte Colony-Stimulating Price Trend, by Type (2017-2028)

    • 4.3 China Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Recombinant Human Granulocyte Colony-Stimulating Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Recombinant Human Granulocyte Colony-Stimulating Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Recombinant Human Granulocyte Colony-Stimulating Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Recombinant Human Granulocyte Colony-Stimulating Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Recombinant Human Granulocyte Colony-Stimulating Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Recombinant Human Granulocyte Colony-Stimulating Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Recombinant Human Granulocyte Colony-Stimulating Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Recombinant Human Granulocyte Colony-Stimulating Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Recombinant Human Granulocyte Colony-Stimulating Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Recombinant Human Granulocyte Colony-Stimulating Market Analysis

    • 7.1 North America Recombinant Human Granulocyte Colony-Stimulating Market, by Type

    • 7.2 North America Recombinant Human Granulocyte Colony-Stimulating Market, by Application

    • 7.3 North America Recombinant Human Granulocyte Colony-Stimulating Market Analysis and Forecast, by Country

      • 7.3.1 United States Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Recombinant Human Granulocyte Colony-Stimulating Market Analysis

    • 8.1 Europe Recombinant Human Granulocyte Colony-Stimulating Market, by Type

    • 8.2 Europe Recombinant Human Granulocyte Colony-Stimulating Market, by Application

    • 8.3 Europe Recombinant Human Granulocyte Colony-Stimulating Market Analysis and Forecast, by Country

      • 8.3.1 Germany Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Recombinant Human Granulocyte Colony-Stimulating Market Analysis

    • 9.1 APAC Recombinant Human Granulocyte Colony-Stimulating Market, by Type

    • 9.2 APAC Recombinant Human Granulocyte Colony-Stimulating Market, by Application

    • 9.3 APAC Recombinant Human Granulocyte Colony-Stimulating Market Analysis and Forecast, by Country

      • 9.3.1 China Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Analysis

    • 10.1 Latin America, Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market, by Type

    • 10.2 Latin America, Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market, by Application

    • 10.3 Latin America, Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Recombinant Human Granulocyte Colony-Stimulating Company Profiles

      • 11.1 Triprime

        • 11.1.1 Triprime Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Triprime Recombinant Human Granulocyte Colony-Stimulating Product Profiles, Application and Specification

        • 11.1.3 Triprime Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Sinovac

        • 11.2.1 Sinovac Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Sinovac Recombinant Human Granulocyte Colony-Stimulating Product Profiles, Application and Specification

        • 11.2.3 Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Kyowa Hakko Kirin

        • 11.3.1 Kyowa Hakko Kirin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Product Profiles, Application and Specification

        • 11.3.3 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Zhaoke

        • 11.4.1 Zhaoke Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Product Profiles, Application and Specification

        • 11.4.3 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Hangzhou Jiuyuan

        • 11.5.1 Hangzhou Jiuyuan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Product Profiles, Application and Specification

        • 11.5.3 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Kawin

        • 11.6.1 Kawin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Kawin Recombinant Human Granulocyte Colony-Stimulating Product Profiles, Application and Specification

        • 11.6.3 Kawin Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Amoytop Biotech

        • 11.7.1 Amoytop Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Product Profiles, Application and Specification

        • 11.7.3 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Shijiazhuang Pharmaceutical

        • 11.8.1 Shijiazhuang Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Profiles, Application and Specification

        • 11.8.3 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Amgen

        • 11.9.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Amgen Recombinant Human Granulocyte Colony-Stimulating Product Profiles, Application and Specification

        • 11.9.3 Amgen Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Gensci

        • 11.10.1 Gensci Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Gensci Recombinant Human Granulocyte Colony-Stimulating Product Profiles, Application and Specification

        • 11.10.3 Gensci Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Qilu Pharmaceutical

        • 11.11.1 Qilu Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Profiles, Application and Specification

        • 11.11.3 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Huaxin

        • 11.12.1 Huaxin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Huaxin Recombinant Human Granulocyte Colony-Stimulating Product Profiles, Application and Specification

        • 11.12.3 Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Recombinant Human Granulocyte Colony-Stimulating Industry Investment Prospect and Risk Assessment

    • 12.1 Recombinant Human Granulocyte Colony-Stimulating Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Recombinant Human Granulocyte Colony-Stimulating Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure Global Recombinant Human Granulocyte Colony-Stimulating Production Value and Growth Rate (2017-2028)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Production Value and Growth Rate (2017-2028)

    • Figure Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Lenograstim (Granocyte) (2017-2028)

    • Figure Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) (2017-2028)

    • Figure Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Chemotherapy Induced Neutropenia (2017-2028)

    • Figure Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Before Blood Donation (2017-2028)

    • Figure Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Stem Cell Transplants (2017-2028)

    • Figure Global Recombinant Human Granulocyte Colony-Stimulating Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Recombinant Human Granulocyte Colony-Stimulating Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Recombinant Human Granulocyte Colony-Stimulating Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Recombinant Human Granulocyte Colony-Stimulating Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Recombinant Human Granulocyte Colony-Stimulating Market Share, by Manufacturer in 2021

    • Figure Global and China Recombinant Human Granulocyte Colony-Stimulating Market Share, by Manufacturer in 2022

    • Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Volume, by Type (2017-2028)

    • Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Type (2017-2028)

    • Figure Global Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Type (2017-2028)

    • Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Value, by Type (2017-2028)

    • Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Value Share, by Type (2017-2028)

    • Figure Global Recombinant Human Granulocyte Colony-Stimulating Price Trend, by Type (2017-2028)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Sales Volume, by Type (2017-2028)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Type (2017-2028)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Type (2017-2028)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Sales Value, by Type (2017-2028)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Sales Value Share, by Type (2017-2028)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Price Trend, by Type (2017-2028)

    • Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Volume, by Application (2017-2028)

    • Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Application (2017-2028)

    • Figure Global Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Application (2017-2028)

    • Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Value, by Application (2017-2028)

    • Table Global Recombinant Human Granulocyte Colony-Stimulating Sales Value Share, by Application (2017-2028)

    • Figure Global Recombinant Human Granulocyte Colony-Stimulating Sales Value Share, by Application (2017-2028)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Sales Volume, by Application (2017-2028)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Application (2017-2028)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Application (2017-2028)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Sales Value, by Application (2017-2028)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Sales Value Share, by Application (2017-2028)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Sales Value Share, by Application (2017-2028)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Production, Import, Consumption and Export (2017-2022)

    • Figure North America Recombinant Human Granulocyte Colony-Stimulating Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Recombinant Human Granulocyte Colony-Stimulating Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Recombinant Human Granulocyte Colony-Stimulating Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Production, Import, Consumption and Export (2017-2022)

    • Table North America Recombinant Human Granulocyte Colony-Stimulating Sales Volume, by Type (2017-2028)

    • Table North America Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Type (2017-2028)

    • Figure North America Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Type (2017-2028)

    • Table North America Recombinant Human Granulocyte Colony-Stimulating Sales Volume, by Application (2017-2028)

    • Table North America Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Application (2017-2028)

    • Figure North America Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Application (2017-2028)

    • Figure United States Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure United States Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Figure Canada Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Table Europe Recombinant Human Granulocyte Colony-Stimulating Sales Volume, by Type (2017-2028)

    • Table Europe Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Type (2017-2028)

    • Figure Europe Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Type (2017-2028)

    • Table Europe Recombinant Human Granulocyte Colony-Stimulating Sales Volume, by Application (2017-2028)

    • Table Europe Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Application (2017-2028)

    • Figure Europe Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Application (2017-2028)

    • Figure Germany Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Figure UK Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure UK Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Figure France Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure France Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Figure Italy Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Figure Spain Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Figure Poland Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Figure Russia Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Table APAC Recombinant Human Granulocyte Colony-Stimulating Sales Volume, by Type (2017-2028)

    • Table APAC Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Type (2017-2028)

    • Figure APAC Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Type (2017-2028)

    • Table APAC Recombinant Human Granulocyte Colony-Stimulating Sales Volume, by Application (2017-2028)

    • Table APAC Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Application (2017-2028)

    • Figure APAC Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Application (2017-2028)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Figure Japan Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Figure India Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure India Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Recombinant Human Granulocyte Colony-Stimulating Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Recombinant Human Granulocyte Colony-Stimulating Sales Value and Growth Rate (2017-2028)

    • Table Triprime Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Triprime Product Profiles, Application and Specification

    • Table Triprime Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sinovac Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sinovac Product Profiles, Application and Specification

    • Table Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Kyowa Hakko Kirin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kyowa Hakko Kirin Product Profiles, Application and Specification

    • Table Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Zhaoke Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Zhaoke Product Profiles, Application and Specification

    • Table Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hangzhou Jiuyuan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hangzhou Jiuyuan Product Profiles, Application and Specification

    • Table Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Kawin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kawin Product Profiles, Application and Specification

    • Table Kawin Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amoytop Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amoytop Biotech Product Profiles, Application and Specification

    • Table Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Shijiazhuang Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Shijiazhuang Pharmaceutical Product Profiles, Application and Specification

    • Table Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amgen Product Profiles, Application and Specification

    • Table Amgen Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Gensci Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Gensci Product Profiles, Application and Specification

    • Table Gensci Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Qilu Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Qilu Pharmaceutical Product Profiles, Application and Specification

    • Table Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Huaxin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Huaxin Product Profiles, Application and Specification

    • Table Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US